EncorafenibEncorafenib
Common
Rarity: Common
The most frequent rarity: most Wikipedia articles become Commons.
Rarity follows how well known the article is: its views on the French and English Wikipedia over a year, and the number of languages it exists in.
At a glance
- Class
- Notion
- Domain
- Science and technology
- In collections
- Nobody has pulled it yet.
What Wikipedia says
Encorafenib, sold under the brand name Braftovi, is an anti-cancer medication used for the treatment of certain melanoma cancers. It is a small molecule BRAF inhibitor that targets key enzymes in the MAPK signaling pathway. This pathway occurs in many different cancers including melanoma and colorectal cancers.
Excerpt from the Wikipedia article “Encorafenib”, under the CC BY-SA 4.0 license. Read the article on Wikipedia
Image: Vaccinationist, Public domain, via Wikimedia Commons.
Open free boosters and add Encorafenib to your collection.
Play for free

